Table 3.
Personal history of COVID-19 and assessment of vaccine uptake (N = 178).
| IBD Patients n = 77 (43.3%) |
Control Group n = 101 (56.7%) |
p-Value | |
|---|---|---|---|
| Tested positive for COVID-19, n (%) | 0.0464 | ||
| yes, asymptomatic infection | 3 (3.9) | 2 (2.0) | |
| yes, mild symptoms | 4 (5.2) | 22 (22.0) | |
| yes, moderate symptoms | 1 (1.3) | 3 (3.0) | |
| yes, severe symptoms/hospitalization | 1 (1.3) | 2 (2.0) | |
| no | 68 (88.3) | 71 (71.0) | |
| Personally knew anyone with COVID-19, n (%) | 0.0886 | ||
| Yes | 48 (62.3) | 76 (77.6) | |
| No | 29 (37.7) | 23 (22.4) | |
| Received COVID-19 vaccine, n (%) | <0.0001 | ||
| yes, 1 dose | 8 (10.4) | 92 (91.0) | |
| yes, 2 doses | 61 (79.2) | 9 (9.0) | |
| yes, 3 doses | 4 (5.2) | 0 (0.0) | |
| not been vaccinated | 4 (5.2) | 0 (0.0) | |
| Vaccinated for influenza, n (%) | 25 (33.8) | 49 (66.2) | 0.082 |